Clinuvel Pharmaceuticals Limited Share Price Xetra
Stocks
UR9
AU000000CUV3
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
14:30:00 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 5.786 EUR | 0.00% |
|
0.00% | - |
| Market Cap | 479M 339M 294M 275M 251M 472M 32.33B 3.24B 1.26B 16.19B 1.27B 1.24B 53.98B | P/E 2026 * |
13.4x | P/E 2027 * | 12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 226M 160M 139M 130M 119M 223M 15.28B 1.53B 598M 7.65B 601M 588M 25.51B | EV / Sales 2026 * |
2.28x | EV / Sales 2027 * | 1.86x |
| Free-Float |
83.79% | Yield 2026 * |
0.64% | Yield 2027 * | 0.84% |
Last Transcript: Clinuvel Pharmaceuticals Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 63 | 31/10/2005 |
Peter Vaughan
DFI | Director of Finance/CFO | 42 | 29/06/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karen Agersborg
BRD | Director/Board Member | - | 28/01/2018 |
Susan Smith
BRD | Director/Board Member | - | 22/09/2019 |
| Chairman | - | 31/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 339M | |
| +0.12% | +3.83% | +43.38% | -1.11% | 79.68B | |
| -3.73% | +3.89% | -1.33% | +25.77% | 50.61B | |
| -0.95% | -2.36% | +15.45% | +167.47% | 48.81B | |
| -0.66% | +3.90% | -48.98% | -47.71% | 46.91B | |
| +2.44% | +1.08% | +62.00% | -23.68% | 30.86B | |
| +5.12% | +13.18% | +148.13% | -37.26% | 25.42B | |
| -0.25% | +0.81% | +47.98% | +83.18% | 24.48B | |
| -0.42% | +4.62% | +0.16% | +193.67% | 21.2B | |
| +0.17% | +2.26% | +70.79% | +169.84% | 16.39B | |
| Average | +0.31% | +3.56% | +37.51% | +58.91% | 38.26B | |
| Weighted average by Cap. | +0.10% | +3.17% | +28.64% | +41.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 99.21M 70.19M 60.81M 56.98M 51.97M 97.7M 6.69B 670M 262M 3.35B 264M 258M 11.18B | 105M 74.01M 64.12M 60.08M 54.8M 103M 7.06B 707M 276M 3.53B 278M 272M 11.79B |
| Net income | 35.72M 25.27M 21.89M 20.51M 18.71M 35.18M 2.41B 241M 94.31M 1.21B 94.88M 92.82M 4.02B | 37.66M 26.64M 23.09M 21.63M 19.73M 37.09M 2.54B 254M 99.44M 1.27B 100M 97.87M 4.24B |
| Net Debt | -253M -179M -155M -145M -132M -249M -17.05B -1.71B -667M -8.54B -671M -657M -28.47B | -285M -201M -174M -163M -149M -280M -19.21B -1.92B -751M -9.62B -756M -740M -32.07B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CUV Stock
- UR9 Stock
Select your edition
All financial news and data tailored to specific country editions
